1. Home
  2. EMBC vs FOCL Comparison

EMBC vs FOCL Comparison

Compare EMBC & FOCL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Embecta Corp.

EMBC

Embecta Corp.

HOLD

Current Price

$3.37

Market Cap

207.1M

Sector

Health Care

ML Signal

HOLD

Logo EDAP TMS S.A. American Depositary Shares

FOCL

EDAP TMS S.A. American Depositary Shares

N/A

Current Price

$5.68

Market Cap

203.7M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
EMBC
FOCL
Founded
1924
N/A
Country
United States
France
Employees
N/A
289
Industry
Medical/Dental Instruments
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
207.1M
203.7M
IPO Year
2021
N/A

Fundamental Metrics

Financial Performance
Metric
EMBC
FOCL
Price
$3.37
$5.68
Analyst Decision
Buy
Analyst Count
2
0
Target Price
$18.50
N/A
AVG Volume (30 Days)
2.4M
44.1K
Earning Date
05-05-2026
N/A
Dividend Yield
6.88%
N/A
EPS Growth
20.90
N/A
EPS
0.67
N/A
Revenue
N/A
N/A
Revenue This Year
$1.17
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$5.13
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.77
$4.76
52 Week High
$15.55
$5.64

Technical Indicators

Market Signals
Indicator
EMBC
FOCL
Relative Strength Index (RSI) 48.77 87.94
Support Level $3.03 $5.30
Resistance Level $3.48 N/A
Average True Range (ATR) 0.14 0.15
MACD 0.06 0.02
Stochastic Oscillator 66.27 100.00

Price Performance

Historical Comparison
EMBC
FOCL

About EMBC Embecta Corp.

Embecta Corp is a medical device company focused on providing solutions to improve the health and well-being of people living with diabetes. It has a broad portfolio of marketed products, including various pen needles, syringes, and safety devices, which are complemented by a proprietary digital application designed to assist people with managing their diabetes. The company predominantly sells products to wholesalers and distributors that sell to retail and institutional channels who in turn sell to patients or use the products to deliver insulin injections to patients. It also provides contract manufacturing services. Geographically, the company derives a majority of its revenue from the United States.

About FOCL EDAP TMS S.A. American Depositary Shares

Edap TMS SA, formerly known as FocalTherics, operates in the Robotic Focal Therapy industry. It develops, manufactures, and markets minimally invasive medical devices across various countries to treat various conditions using proprietary focused ultrasound technology. The company's flagship platform, Focal One Robotic HIFU, combines imaging, real-time treatment planning, robotic precision, and high intensity focused ultrasound (HIFU) technology. It is focused on expanding the clinical adoption of its patented focused ultrasound-based robotic therapy platforms through continued innovation, clinical evidence generation, physician education, and various market development initiatives.

Share on Social Networks: